Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Read more at The New York Times
Topics
-
Ozempic among drugs targeted in upcoming Medicare price negotiations
Investors fret Novo Nordisk’s blockbuster treatments and other medicines could incur price cutsFinancial Times - 2h -
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.CNBC - 2h -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - 4h -
The next 15 drugs chosen for Medicare negotiation
The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare ...The Hill - 3h -
White House says popular weight-loss drug Ozempic subject to Medicare talks
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.MarketWatch - 4h -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - 4h -
CMS to seek Medicare negotiations on Ozempic price
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...The Hill - 5h -
Biden administration picks 15 more drugs for Medicare negotiation
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did ...The Hill - 6h -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9
More from The New York Times
-
China Says Economy Grew 5% Last Year, Driven by Exports
Analysts say they see signs of malaise in China’s domestic economy, but those problems were offset mainly by robust exports and a $1 trillion trade surplus.The New York Times - 16h -
What Did Trump’s Tax Cuts Do?
Economic upheaval caused by the pandemic has clouded analysts’ ability to understand the effects of the 2017 tax law. Republicans call it a huge success and want to extend it anyway.The New York Times - 6h -
Spain Overhauls Domestic Violence System After Criticism
Spain uses an algorithm to score how likely a domestic violence victim is to be abused again. A Times investigation last year identified flaws in the system.The New York Times - 14h -
Facing a Flurry of U.S. Sanctions, China Prepares to Hit Back
With days until Donald Trump is sworn in, China is bracing for a trade war, aiming at industries as diverse as semiconductors, apparel and industrial plastic.The New York Times - 8h -
What to Know About Plane Maintenance After the South Korean Crash
Airlines have been increasingly outsourcing repair and upkeep work to other countries, but experts and consumer groups disagree about its impact on safety.The New York Times - 9h
More in Business
-
Hopes are high that home builders will fix America’s housing crisis. But the data tell a different story.
Construction of new homes jumped in December, but a look at 2024 overall shows builders weren’t ramping up construction despite strong demand.MarketWatch - 5m -
Trump is a ‘wild card’ for the stock market, this trader says. He’s buckling up.
Volatility is the “new norm,” market pro Jeff Bierman predicts.MarketWatch - 11m -
Top Supreme Court lawyer charged with tax evasion related to poker winnings
Lawyer Tom Goldstein co-founded SCOTUSblog, which chronicles Supreme Court cases. He has appeared dozens of times before the high court.CNBC - 16m -
How to ‘Trump-proof’ your 401(k)
An investment idea for the terrified.MarketWatch - 19m -
‘He’s twice mentioned divorce’: My new husband told me he’ll have $500,000 for retirement, but he’s $80,000 in debt. How do I protect myself?
“Six months after we married, we had planned to get pre-qualified for a mortgage with the intention of selling both our homes.”MarketWatch - 21m